FDA Approves NovoTTF-100L Plus Chemo for Malignant Pleural Mesothelioma
The FDA has approved the NovoTTF-100L System in combination with pemetrexed and platinum-based chemotherapy for the frontline treatment of patients with unresectable, locally advanced or metastatic malignant pleural mesothelioma.
Source: OncLive